noscript

News and Announcements

Analytica Limited (ASX: ALT) completes Renouncable Entitlement Offer with over $1 million raised

  • Published June 08, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • Analytica Limited has announced the successful completion of the renounceable entitlement offer with $1.045m raised.
  • The Entitlement offered one new share for every eight shares held on the 21 of September 2017.
  • The entitlement offer aimed to raise funds to continue the development of their PeriCoach system.

Analytica Limited has announced the successful completion of their entitlement offer that was announced in September 2017. The renounceable entitlement offer resulted in $1.045m raised through options exercised before the expiration of two options provided. The Entitlement offered one new share for every eight shares held on the 21 of September 2017. Option 1 stated that shares subscribed to are exercisable at $0.005 on or before 31 January 2018, or Option 2 exercisable at $0.005 on or before 31 May 2018. Following Option 1, a total of $919k worth of exercised options was raised and Option 2 raised a total of $1.045k through the exercised options. A further $487k was raised from private placements with unlisted options exercisable at the same $0.005.

The entitlement offer aimed to raise funds to continue the development of their PeriCoach system. PeriCoach is a medical system that allows remote physicians to monitor a woman’s Stress Urinary Incontinence condition. The support of shareholders in pursuing this goal of development was appreciated by Analytica Limited, and the shares will be allocated on 13 June 2018.

 

About Analytica Limited (ASX: ALT)

Analytica Limited (ASX: ALT) is an Australian medical device manufacturing and commercialisation company.

Request Info

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now